Caffeine
- Generic Name
- Caffeine
- Brand Names
- Anacin, Arthriten Inflammatory Pain, Ascomp, Bc Arthritis, Bc Original Formula, Cafcit, Diurex, Dvorah, Esgic, Exaprin, Excedrin, Excedrin Tension Headache, Fioricet, Fioricet With Codeine, Fiorinal, Goody's Extra Strength, Goody's Headache Relief Shot, Goody's PM, Midol Complete, Midol Cramps & Bodyaches, Migergot, Norgesic, Norgesic Forte, Orbivan, Orphengesic, Pamprin Max Formula, Peyona, Stanback Headache Powder Reformulated Jan 2011, Trezix, Trianal, Trianal C, Triatec, Triatec-8, Vanatol, Vanatol S, Vanquish, Vivarin, Peyona (previously Nymusa), Gencebok
- Drug Type
- Small Molecule
- Chemical Formula
- C8H10N4O2
- CAS Number
- 58-08-2
- Unique Ingredient Identifier
- 3G6A5W338E
- Background
Caffeine is a drug of the methylxanthine class used for a variety of purposes, including certain respiratory conditions of the premature newborn, pain relief, and to combat drowsiness. Caffeine is similar in chemical structure to Theophylline and Theobromine. It can be sourced from coffee beans, but also occurs naturally in various teas and cacao beans, whic...
- Indication
Caffeine is indicated for the short term treatment of apnea of prematurity in infants and off label for the prevention and treatment of bronchopulmonary dysplasia caused by premature birth. In addition, it is indicated in combination with sodium benzoate to treat respiratory depression resulting from an overdose with CNS depressant drugs. Caffeine has a broa...
- Associated Conditions
- Acute Pain, Chronic Lung Disease of Prematurity, Common Cold, Dyspepsia, Fatigue, Fever, Flu caused by Influenza, Headache, Menstrual Pain, Myalgia, Pain, Pain caused by Rheumatism, Primary apnea of premature newborns, Respiratory Depression, Somnolence, Tension Headache, Toothache, Under-eyes Dark Circles, Vascular Headaches, Moderate Pain
- Associated Therapies
- Analgesia, Antacid therapy, Athletic Performance
EIMD Mechanisms Causing Force Loss
- First Posted Date
- 2014-04-29
- Last Posted Date
- 2017-06-05
- Lead Sponsor
- University of Oklahoma
- Target Recruit Count
- 3
- Registration Number
- NCT02125643
- Locations
- 🇺🇸
Sensory and Muscle Function Lab 7, Norman, Oklahoma, United States
The Effects of Caffeine on Pain-Based Pacing During a Cycling Time-Trial
- First Posted Date
- 2014-04-16
- Last Posted Date
- 2017-06-05
- Lead Sponsor
- University of Oklahoma
- Target Recruit Count
- 15
- Registration Number
- NCT02115763
- Locations
- 🇺🇸
University of Oklahoma Sensory and Muscle Function Lab, Norman, Oklahoma, United States
A Study of Caffeine on Cardiac Arrhythmias
- Conditions
- Interventions
- First Posted Date
- 2014-03-24
- Last Posted Date
- 2016-12-22
- Lead Sponsor
- Ottawa Heart Institute Research Corporation
- Target Recruit Count
- 160
- Registration Number
- NCT02095405
- Locations
- 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
Effect on Energy Metabolism at Cellular Level of Diet Plus Treatment With Ephedrine and Caffeine in Obesity
- Conditions
- Interventions
- First Posted Date
- 2014-01-29
- Last Posted Date
- 2014-01-29
- Lead Sponsor
- Istituto Auxologico Italiano
- Target Recruit Count
- 13
- Registration Number
- NCT02048215
- Locations
- 🇮🇹
Istituto Auxologico Italiano -Ospedale San Giuseppe, Verbania, VB, Italy
Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate
- Conditions
- Interventions
- First Posted Date
- 2013-09-25
- Last Posted Date
- 2024-10-16
- Target Recruit Count
- 47
- Registration Number
- NCT01950520
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Efficacy and Safety of Ibuprofen and Caffeine in Dental Pain
- Conditions
- Interventions
- First Posted Date
- 2013-08-27
- Last Posted Date
- 2016-11-16
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 562
- Registration Number
- NCT01929031
- Locations
- 🇺🇸
1335.1.202 Boehringer Ingelheim Investigational Site, Salt Lake City, Utah, United States
Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics
- Conditions
- Interventions
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2014-04-21
- Target Recruit Count
- 117
- Registration Number
- NCT01845194
- Locations
- 🇩🇪
Dept. of Clinical Pharmacology, Georg-August-University of Goettingen, Goettingen, Germany
Cognitive Hyper-performance - Effects of Stimulating Substances in Chess-players
- Conditions
- Interventions
- First Posted Date
- 2013-04-18
- Last Posted Date
- 2013-04-18
- Lead Sponsor
- K. Lieb
- Target Recruit Count
- 40
- Registration Number
- NCT01834547
- Locations
- 🇩🇪
Department of Psychiatry and Psychotherapy, Mainz, Germany
Caffein Consumption and Response Inhibition
- First Posted Date
- 2013-03-20
- Last Posted Date
- 2013-09-25
- Lead Sponsor
- Uppsala University
- Target Recruit Count
- 21
- Registration Number
- NCT01815203
- Locations
- 🇸🇪
Uppsala University, Uppsala, Sweden
Early Versus Routine Caffeine Administration in Extremely Preterm Neonates
- First Posted Date
- 2013-02-05
- Last Posted Date
- 2018-12-11
- Lead Sponsor
- Sharp HealthCare
- Target Recruit Count
- 21
- Registration Number
- NCT01783561
- Locations
- 🇺🇸
Sharp Memorial Hospital, San Diego, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.